GP-350

N/A

Report date: 2025/12/31 20:01:55

Base Information

Drug NameGP-350
Drug Alias NameGP350GP-350
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsLymphomaEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZeno Therapeutics Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZeno Therapeutics Pte Ltd
Inactive CompaniesN/A
Active IndicationsLymphomaEpstein-Barr Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A